Facilitators and barriers to Pre-Exposure Prophylaxis continuation in Adolescent girls and young women post-trial participation in Hillbrow, Johannesburg: A cross-sectional study

Abstract

HIV incidence amongst adolescent girls and young women (AGYW) is on the rise. Pre-exposure Prophylaxis (PrEP) trials prevent HIV amongst AGYW who are at heightened risk of acquiring HIV during trial participation until study exit. To prevent HIV amongst AGYW PrEP is required to be continued post PrEP trial participation. It is important to determine if AGYW continue with PrEP or whether they have discontinued PrEP after study exit and the reasons influencing post-trial PrEP continuation.